Skip to main content
MapleLMS Implementation
Conferences and Meetings 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster III

612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster III

Short name: 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster III
Course start date: 11/08/2025

Sections

General
0 activities

Clinical Characteristics and Prognostic Analysis of Testicular Relapse in Pediatric Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study from China
Evaluating the Effectiveness and Security of Antifungal Prophylaxis in Acute Lymphoblastic Leukemia Induction Chemotherapy
Initial Cerebrospinal Fluid Blast Clearance Rate in Pediatric B-Lymphoblastic Leukemia Is Associated with Overall Survival
Kinetics of Blast Clearance in Cerebrospinal Fluid (CSF) Detected on Flow Cytometric Immunophenotyping (FCM), but Negative By Cytopathology in Newly Diagnosed Acute Lymphoblastic Leukemia Patients
Optimising Therapy in FLT3-Mutated Acute Myeloid Leukaemia
Relapse Risk and Outcome of Discontinuing Asparaginase in Children with Acute Lymphoblastic Leukemia
Retrospective Cohort Analysis of Response and Survival of Children, Adolescents, and Young Adults (CAYA) with Relapsed and/or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoma (T-LL) Treated with Curative Intent
The Incidence of CNS Relapse in Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) and Its Impact on Clinical Outcome: Results from Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Vincristine Dose Adjustments in Acute Lymphoblastic Leukemia: Impact on Treatment Outcomes and Neuropathy